Title	Topics
Point-of-Care Molecular Diagnostics Market and Technology Assessment	Analysis of current utilization and needs for rapid point-of-care molecular tests for infectious disease diagnosis. Determination of test requirements, utilization trends of POC molecular tests (including COVID impact), test menu requirements and price requirements.
Point-of-Care Allergy Testing Market Analysis	Assessment of products and emerging technologies for allergy diagnostics in physician’s office and alternate site laboratories. Determination of product requirements, test volumes and trends, pricing requirements, test panel requirements, and alternative methods used for allergy diagnostics.
Viral Genotyping Products Market Analysis	Analysis of U.S. market for viral genotyping diagnostic products in units and dollars and forecast market size. Identification of leading competitors and products, supplier sales and market share. Analysis of pricing and reimbursement trends.
DNA Microarray and Lab-on-Chip Market and Technology Assessment	Analysis of genomic and proteomic microarray and lab-on-chip technologies for diagnostics and life science applications including assessment of market entry barriers, regulatory factors including cost and time for regulatory approvals, and competitive technologies. Study included in-depth interviews with 37 experts in microarray and lab-on-chip applications in the U.S. and Europe.
Worldwide ELISA Market Analysis	Assessment of the global clinical laboratory market for ELISA products including market size, pricing, test volume trends, existing and new products. Study included in-depth interviews with clinical laboratory directors in the U.S., Europe, Asia/Pacific and Latin America.
Blood Genotyping Technology and Market Analysis	Assessment of current market status and forecast trend in adoption of DNA typing technology in hospital blood bank laboratories worldwide. Development of market size and growth estimates, supplier sales and market share analysis, and technology utilization trends.
Worldwide Transplantation Testing Market Assessment	Analysis of global markets for immunological and DNA transplant testing products including market size and growth rates, product pricing, adoption factors, and technology utilization. The study included a survey which polled approximately 4,000 transplantation medicine laboratories worldwide.
Whole blood glucose market and technology tracking program	Monthly tracking of new developments in whole blood glucose monitoring including new sensor technologies, continuous glucose monitoring, emerging companies, partnerships and acquisitions, new product introductions, patents and patent applications, and market trends.
Bedside Critical Care Testing Market Assessment	Analysis of the global market opportunity for bedside critical care monitoring technology, including assessment of competitors; barriers to adoption including regulatory, cost and product performance barriers; test menu requirements; and market penetration strategies.
Assessment of Market Opportunity for a New Rapid Detection Technology	Market opportunity assessment for a new technology with applications in rapid sensitive detection of infectious diseases, cancer, and cardiovascular disease. Analysis of market size, market trends, competing technologies and companies, adoption barriers, regulatory issues, and technology requirements. Assessment of health care system trends in the U.S. and Europe and their impact of market opportunity.
Point-of-Care Cardiovascular Risk Assessment Market Opportunity Assessment	Analysis of current market opportunities in POC cardiovascular risk assessment products. Identification and characterization of key players, market analysis including unit and dollar volume market size and forecasts, product comparisons, and assessment of competitor strategies.
Point-of-Care Testing Product Development and Business Development Strategy	Analysis of current market opportunities in hospital point-of-care and alternate site testing. Development of technology and business development strategy for expansion of client into global POC testing products market. Identification of sources for new technologies and assistance in evaluation of technologies. Identification of target partners for product development and market penetration.
Analysis of Market Opportunity for a New Point-of-Care Hematology Testing Technology	Assessment of market size and trends, technology requirements, reimbursement and market acceptance barriers, competitors and pricing strategies for the point-of-care/physician's office laboratory testing market.
U.S. Immunodiagnostics Market Assessment	Assessment of the U.S. market for immunodiagnostic products including market size and growth trends, competitors, technology trends, new markers, and emerging segments of the market. Analysis of the breakdown of the immunodiagnostics market by technology and application
Assessment of Applications of Nanotechnology in In-Vitro Diagnostics	Identification of emerging and development-stage nanotechnology applications in in-vitro diagnostics. Search for companies and research groups developing nanotechnology applications, and analysis of market opportunities. Results included identification of leading research groups and companies, development status, identification of barriers to commercialization, and development of a database of key contacts.
Molecular Diagnostics Automation Strategy Development	Conducted focus groups and market analysis to identify optimum strategy for development of automated molecular diagnostics systems. Evaluation of various product scenarios and determination of key factors driving market acceptance.
Point-of-Care Test Cost and Utilization Assessment	Determination of costs for laboratory-based versus point-of-care testing. Assessment of test volume for key critical care tests in U.S. hospitals including blood gas, electrolyte, and chemistry tests. Determination of chemistry test volume in U.S. physician's office labs.
New Medical Product Applications Assessment	Assessment of OEM and proprietary product opportunities in the clinical diagnostics and medical device industry. Involved detailed assessment of existing and development stage products for sample collection, sample processing, sample storage and shipment, wound management, and other applications in the clinical laboratory and patient care.
Alternate Site Testing Product Opportunity Assessment	Assessment of the market opportunity for equipment and consumables for a novel new approach to in-vitro diagnostic testing in alternate site health care settings. Methodology employed interviews with physicians practicing in a wide range of specialties to determine testing needs, current practices, and cost impacts of diagnostic testing, and to obtain opinions on the relative merits of various alternative product configurations.
Blood Gas/Electrolyte/Co-oximetry Market Assessment	Assessment of the worldwide market for equipment and consumables for central laboratory, point-of-care, and patient-attached blood gas/electrolyte/co-oximetry analysis in the U.S., Europe, Asia/Pacific and the Rest of World market segments. Identify trends in the health care market that will drive future utilization of these products. Compute sales and market share for key competitors and provide detailed profiles on each supplier.
Assessment of Noninvasive Blood Glucose Monitoring Technology and Market	Assessment of a new technology for noninvasive monitoring of blood glucose and of a potential partnership opportunity to pursue development of this technology for a non-U.S. based client. Analysis of market opportunity, technology feasibility assessment, and due diligence evaluation of target company and personnel.
Global In-Vitro Diagnostics Market Study	Comprehensive analysis of the worldwide in-vitro diagnostics market including detailed analysis of cost and utilization trends, market size and growth rates, and leading suppliers’ sales and market shares in the chemistry, immunochemistry, TDM/Drugs of Abuse testing, coagulation, microbiology, blood gas/electrolyte, urinalysis, hematology/flow cytometry, blood screening and allergy testing segments. The study involved a worldwide mail survey of over 400 clinical laboratories plus a telephone survey of approximately 100 laboratory directors. In addition, information was obtained from industry sources, and the most recent data from government agencies was compiled.
Worldwide Point-of-Care Testing Market Study	Worldwide clinical diagnostics market; worldwide point-of-care testing market including hospital, physician’s office and home/self-testing segments; analysis of key competitors in each segment including sales and market share by region.
Assessment of Blood Testing Practices in the Intensive Care Unit	Top ten in-vitro diagnostic tests by test volume performed in the intensive care setting; test volume by patient type/disease severity; cost per test data; intensive care user survey.
Assessment of Automated Specimen Handling Product Opportunities	Survey of prospective users regarding new product concepts; market size estimate; price elasticity analysis; cost/benefit analysis.
Analysis of U.S. and European Markets for Nucleic Acid Probe Clinical Diagnostic Products	Mail and telephone survey of 120 labs to determine utilization trends, product preferences, and future purchase plans; market estimate and forecast; market share analysis; disease incidence and prevalence analysis for U.S., Europe and Japan; assessment of regulatory approval factors; comprehensive product assessment including analysis of development-stage products.
Physician’s Office Testing Market and Technology Assessment	Assessment of CLIA status and impact on Physician’s Office Testing market; types of testing performed; market estimate and forecast; impact of managed care; analysis of existing and development-stage products for the physician’s office laboratory; assessment of physiologic testing products for the physician’s office.
Analysis of Markets for Glycated Hemoglobin Testing Products	Test volume and sales estimates; existing products assessment including installed base, annual sales, and pricing.